Starmer weighs joining Trump’s Gaza peace board
Keir Starmer is weighing whether to join Donald Trump’s proposed Gaza peace board amid diplomatic talks with Washington.
Every story in this section, newest first — page 330 of 373.
Keir Starmer is weighing whether to join Donald Trump’s proposed Gaza peace board amid diplomatic talks with Washington.
Kevin Rudd will step down as Australia’s ambassador to the US at the end of March, a year ahead of schedule.
Global central bank leaders have rallied behind Fed chair Jerome Powell as a US justice department investigation sparks fears over political pressure.
The US has approved Nvidia’s H200 AI chip exports to China, despite warnings that the move could boost Beijing’s military capabilities.
Former New York City mayor Eric Adams unveiled a new memecoin project called NYC Token during a press conference in Times Square shortly after leaving office on 1 January.
Bank of America Corp. (NYSE:BAC) reported fourth-quarter net income of $7.65 billion, or 98 cents per share, as the nation’s second-largest lender successfully harnessed a rebound in investment banking and resilient consumer spending to overcome a high bar set by analysts.
December’s CPI landed exactly at 2.7%, with a slightly cooler core print giving markets mild relief but no big Fed pivot.
SemiLEDs Corporation (NASDAQ:LEDS) reported a sharp sequential decline in revenue for its first fiscal quarter of 2026 on Wednesday, as the Hsinchu-based chipmaker moved past a period of high-volume equipment sales that had temporarily inflated its top line.
Reserve Bank of Australia governor Michele Bullock has joined a group of leading central bankers in publicly backing US Federal Reserve chair Jerome Powell.
Energous Corporation (NASDAQ:WATT), a pioneer in over-the-air (OTA) wireless power networks, announced preliminary results for fiscal year 2025 on Tuesday, highlighting a dramatic expansion in commercial adoption.
AstraZeneca (NASDAQ:AZN) announced Tuesday at the J.P. Morgan Healthcare Conference that it has acquired Boston-based Modella AI, marking the first time a major pharmaceutical company has fully absorbed a specialized artificial intelligence firm.
Meta Platforms (NASDAQ:META) and EssilorLuxottica are in discussions to double their production capacity for AI-powered smart glasses to 20 million units annually by the end of 2025, according to people familiar with the matter.
Polygon Labs announced the acquisition of Coinme and Sequence in a combined deal valued at $250 million, marking a strategic shift towards becoming a regulated payments-focused company.
Delta Air Lines (NYSE:DAL) signaled a major shift in its widebody strategy Tuesday, placing its first direct order for the Boeing 787 Dreamliner to anchor its international expansion through the next decade.
Sono-Tek Corporation (NASDAQ:SOTK) reported a significant jump in profitability for its third fiscal quarter, as a strategic pivot toward complex, high-value coating systems offset a slight dip in overall revenue.
The U.S. Consumer Price Index (CPI) rose at an annual rate of 2.7% in December 2025, matching the previous month’s pace and signaling that the long-awaited "last mile" to the Federal Reserve’s 2% target remains elusive.
ImmunityBio (NASDAQ:IBRX) announced positive results Tuesday from its ANKTIVA® clinical program, signaling a potential paradigm shift in the treatment of advanced non-small cell lung cancer (NSCLC) for patients who have exhausted standard-of-care options.
Franklin Templeton has updated two long-standing institutional money market funds to support stablecoin reserves and onchain cash activity without creating new crypto-native products.
The Baldwin Group (NASDAQ:BWIN) announced Tuesday the completion of its acquisition of Creisoft, better known as Obie, a Chicago-based insurtech pioneer.
AudioEye (NASDAQ:AEYE) announced Tuesday its 40th consecutive period of record revenue, signaling that the global push for digital accessibility continues to fuel the company’s expansion.
BriaCell Therapeutics Corp. (NASDAQ:BCTX) announced Tuesday that the first patient in its Bria-OTS trial achieved an 11-month sustained complete resolution of a lung metastasis, providing a significant early validation for the company’s personalized "off-the-shelf" immunotherapy platform.
U.S. Bancorp (NYSE:USB) agreed to acquire financial services firm BTIG in a deal valued at as much as $1 billion, a strategic move by the fifth-largest U.S. bank to aggressively expand its footprint in investment banking and institutional trading.
BNY (NYSE:BNY) reported fourth-quarter 2025 results that surpassed Wall Street’s expectations, fueled by a surge in fee-based income and a record expansion of its custody empire.
Fortress Biotech Inc. (Nasdaq: FBIO) and its majority-owned subsidiary, Cyprium Therapeutics, secured a historic regulatory victory Tuesday as the U.S. Food and Drug Administration approved ZYCUBO® (copper histidinate) as the first-ever treatment for Menkes disease.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy